Arkolith/Insider Trading/VRDN/Form 4/A

Beetham Thomas W.

Chief Operating OfficerViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4/A · filed Mar 9, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2026Tax withholding(F)3K$30.19$92K13K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001193125-26-099014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML